Ultralife (ULBI): Director bought ~$12K
Bradford T Whitmore, Director at Ultralife, bought ~$12K of Ultralife shares.
- ~$12K
- Approx. value · 2,140 sh @ $5.72
- 1.05M
- Holds after · shares reported
- Traded
- May 15, 2025
- Filed
- May 15, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 13, 2025Insider · 2 peopleInsiders: 2 purchases (~$64K)
- May 14, 2025Insider · 3 peopleInsiders: 3 purchases (~$137K)
- May 15, 2025 · this disclosureInsiderDirector purchased ~$12K of ULBI shares in the open market
What came next
- May 23, 2025InsiderDirector purchased ~$65K of ULBI shares in the open market
- Jun 13, 2025Insider · 2 peopleInsiders: 2 purchases (~$88K)
- Aug 19, 2025InsiderDirector purchased ~$104K of ULBI shares in the open market
- Aug 20, 2025InsiderDirector purchased ~$85K of ULBI shares in the open market
- Aug 21, 2025InsiderDirector purchased ~$197K of ULBI shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Ultralife
For Ultralife, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ULBI page.
Other recent filings by Bradford T Whitmore, Director
- SEC Form 4 at Ultralife (ULBI)May 26, 2026
- SEC Form 4 at Ultralife (ULBI)May 26, 2026
- SEC Form 4 at Ultralife (ULBI)May 26, 2026
- SEC Form 4 at Ultralife (ULBI)Mar 16, 2026
- SEC Form 4 at Ultralife (ULBI)Mar 16, 2026
The full history of Bradford T Whitmore, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Ultralife (ULBI) insider traded, and how much?
Bradford T Whitmore, Director at Ultralife, bought ~$12K of Ultralife shares. 2,140 shares at $5.72, open market.
When did it happen, and when was it made public?
Traded: May 15, 2025. Filed: May 15, 2025.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Ultralife recently?
For Ultralife, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the ULBI page.
Does this mean ULBI stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Ultralife
- SEC Schedule 13DOct 29, 2026
- USAspending.gov award recordSep 20, 2026
- USAspending.gov award recordJul 1, 2026
- USAspending.gov award recordJun 29, 2026
- SEC Form 4May 26, 2026
- SEC Form 4May 26, 2026
Everything OQRO holds on this company is on its ULBI page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
